There's no 8-K from Trovagene on the 25th. You guys should fact check before jumping on board with what people say on the internet.
Thank you mlbull for some sanity. I like TROV but jeez there are some crazy comments on here, like those hoping for a low secondary offering price to be able to buy more - as if the amount of dilution or PPS won't affect the value of one's holding. I'm in, holding long and strong, but NOT planning on adding to my position with this secondary. It is still a speculative buy in the vast world of stocks and those following it should treat it as such. No more than a few percent of a portfolio should be in a company like this.
This is a board for TROV, not BIOC. And good to remind yourself of Cramer's stock-picking track record before regurgitating his recommendations here.
lune - the "bad news day" refers to the fact that the overall market is tanking. The good news is the TROV-specific news. Sweet jesus.
Yet another example today of why it's dumb to try and time the markets - I thought for sure biotechs would be hammered today after the Greek vote (not that there SHOULD be any impact) and seeing futures universally down last night. But I've also learned to trust my fundamental analysis and stick strong through tough times, always with a bit of dry powder for when the markets get irrationally bearish. Nice day today for anyone holding micro- and small-cap biotechs. TGTX will have its day. Its market cap should be closer to $2B by year's end.
I know squat about TA but if a bullish engulfing candle is another way of saying the share price went up, then I agree - good sign.
Conviction is nice, though it's still true that the institutions will at some point have to take their profit - whereas the one sure buyer of your stock is the short seller, as Buffett says. I've been holding since $9 and have a several year timeline on OVAS, so it'll have its day. Take the long view, just don't get antsy and sell too early out of frustration from lack of share price movement.
I'm long, but I've never thought of high institutional ownership as a positive sign. After all, all they can do from that point is sell. And refreshing is right - they've made the claims and now the next catalyst will be showing that they can make money with their product.
I agree with these picks - don't know TXTG but do know TGTX. My list: STML, TGTX, TKAI, CARA, VNDA, VSTM. Been waiting on STML for about 2 years now but am holding steady - feel we'll finally see some action in the next 6 months and don't want to miss the boat. Good luck all.
Well you bought on Friday... so what is there to say? Timing the market is a tricky game, especially in small, thinly-traded biotechs. There are maybe 2-3 times I have successfully waited a day or two for a pullback and have gotten a better entry point. But way more frequently I've tried to get cute and have missed my chance. Like most recently with a buy order on ESPR at $15 when it was at $16. Oops. I've learned to just buy at the time I decide a stock is worth buying, and not to try to time the market. Your call, but generally those of us looking at stocks like ORPN are looking for multi-baggers, and so getting a small, even 10% pullback before entry is not so significant when compared to the risk of waiting and missing out.
Well when you told people to wait, on June 15, the stock closed at 6.74. And yesterday it closed at 7.12. So unless you managed to pick out intra-day highs and lows like a savant, you paid more by waiting.
Strong work tango! I like the bold prediction and will take $72 for now, having held since $12.2. Nice how one winner can just carry your portfolio huh?
Goodbye all. This has been a mediocre board with few posts of value, but it was fun interfacing with the few of you who actually had insight into this company. Glad some of you made some $$. I expect the buyout to be completed in the next few weeks. rrtzrealmd - here's a final AHAHAHAHA to you. Nice job hiding after being so horribly wrong in absolutely everything you had to say about HPTX. They're now bringing in $120 million a year from just 500 patients - oops! Hope you learn from your mistakes.
So that strategy makes you feel smart in this case, but it is a very bad one long-term - basically the opposite of Buffett's advice about fear and greed. The market reacts erratically and irrationally, and stuff like listening to boring conference calls ends up being pretty important. If the science is sound and the results are real, share price will follow.